Visfatin levels showed a strong positive correlation with insulin resistance, followed by the free androgen index (FAI) in PCOS cases irrespective of BMI, suggesting an adverse effect of visfatin on PCOS pathophysiology among non-obese women. This evidence concerns the gene NAMPT and polycystic ovary syndrome.